Dr Thereza C Tosado Ortiz, MD | |
568 Ne 255th St, Cross City, FL 32628-5877 | |
(352) 498-4741 | |
(352) 498-4337 |
Full Name | Dr Thereza C Tosado Ortiz |
---|---|
Gender | Female |
Speciality | General Practice |
Location | 568 Ne 255th St, Cross City, Florida |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922231430 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 17726 (Puerto Rico) | Primary |
208D00000X | General Practice | ACN 384 (Florida) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Thereza C Tosado Ortiz, MD 24518 Sw 13th Ln, Newberry, FL 32669-4492 Ph: (787) 378-3084 | Dr Thereza C Tosado Ortiz, MD 568 Ne 255th St, Cross City, FL 32628-5877 Ph: (352) 498-4741 |
News Archive
Alexza Pharmaceuticals, Inc. announced today that it has filed a universal shelf registration statement with the Securities and Exchange Commission (SEC) that, if declared effective by the SEC, will allow the Company to sell, from time to time, up to $75 million of its common stock, preferred stock, debt securities and/or warrants, either individually or in units, in one or more offerings.
Regenerative medicine company, Mesoblast Limited, today announced that its United States associate company, Angioblast Systems, has been awarded $1.2 million in grants under the United States Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Metabolically healthy obesity – where an individual has a Body Mass Index of greater than 30 but does not appear to be at increased risk of the health complications usually associated with excess weight – has only been recently widely recognised by medical practitioners.
Using a patient's own stem cells, researchers at Johns Hopkins have corrected the genetic alteration that causes sickle cell disease (SCD), a painful, disabling inherited blood disorder that affects mostly African-Americans. The corrected stem cells were coaxed into immature red blood cells in a test tube that then turned on a normal version of the gene.
› Verified 4 days ago